We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Does Treatment Sequence Matter in Esophageal Cancer?
Recent findings suggest no significant overall survival difference for patients with locally advanced esophageal squamous cell carcinoma who had neoadjuvant vs adjuvant therapy. Medscape Medical News
-
Transforming Breast Cancer Detection in Low/Middle Income Countries
Soumen Das, MS, FACS, discussed the BCRADS-2 study and its potential to transform early breast cancer detection in low- and middle-income countries. In this video, Soumen Das, MS, FACS, breast oncologist and surgeon at Tata Memorial Hospital in Kolkata, India, discussed the BCRADS-2 study and its potential to transform early breast cancer detection […]
Source -
The Lowdown on Low-Dose Aspirin for Primary Prevention
Eric Topol reviews the data for low-dose aspirin, including the guidelines, longer follow-up, and the question of its use for cancer prevention. Medscape
-
Proactive Approach May Prevent Fractures in Celiac Disease
Study finds more than 13% prevalence of low bone mineral density in younger patients with celiac disease and a rising association with osteoporosis in patients ages 45 and up. Medscape Medical News
-
CREST-2 and Asymptomatic Carotid Stenosis Management
CREST-2 may end routine CEA for asymptomatic carotid stenosis, but its message is nuanced, raising new questions about patient selection, stenting, and when intervention still makes sense, experts say. Medscape Medical News
-
Endoscopic Gastrostomy Safer Than Surgery in Global Study
Percutaneous endoscopic gastrostomy is associated with better safety and patient-centered outcomes than surgical gastrostomy and radiologic gastrostomy, a recent study shows. Medscape Medical News
-
Why Do So Many Head and Neck Cancer Trials Fail?
A recent retrospective study identifies key factors contributing to high failure rates of clinical trials evaluating treatments for head and neck squamous cell carcinoma. Medscape Medical News
-
Roche Obesity Drug Shows 22.5% Weight Loss as It Seeks to Catch Up With Lilly, Novo
Roche’s experimental obesity drug, which works in a similar way to Eli Lilly’s Zepbound, produced as much as 22.5% weight loss in a mid-stage trial, underpinning the Swiss… Reuters Health Information